SCHEMBL7714769

SCHEMBL7714769

COC(=O)c1ccccc1N1CCC(NCCN)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 1/20 0.45
MYC P01106 1/20 0.44
KDM4E B2RXH2 5/20 0.43
DRD4 P21917 1/20 0.43
DRD3 P35462 1/20 0.43
KMT2A Q03164 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
NPY1R P25929 1/20 0.43
CHRM1 P11229 1/20 0.42
DRD2 P14416 1/20 0.42
BDKRB1 P46663 1/20 0.42
ALDH1A1 P00352 4/20 0.42
HPGD P15428 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
MAPT P10636 1/20 0.42
RAB9A P51151 1/20 0.42
CHRM2 P08172 2/20 0.42
CHRM5 P08912 2/20 0.42
TSHR P16473 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7711170 0.86 NPC1 (0.55) KDM4EKMT2ACHRM1DRD2ALDH1A1
SCHEMBL7719028 0.85 MYC (0.44) OPRK1MYCKDM4EKMT2AL3MBTL1
SCHEMBL7711282 0.84 OPRK1 (0.46) OPRK1KDM4EDRD4DRD3L3MBTL1
SCHEMBL7711060 0.83 DRD2 (0.51) OPRK1KDM4ENPY1RCHRM1DRD2
SCHEMBL7714901 0.80 DRD2 (0.50) KDM4EDRD3KMT2ADRD2ALDH1A1
SCHEMBL13698798 0.79 ALDH1A1 (0.59) MYCKDM4EKMT2AL3MBTL1BDKRB1
SCHEMBL7715920 0.78 ADRB1 (0.45) KDM4EDRD3KMT2ACHRM1DRD2
SCHEMBL7715017 0.77 HRH1 (0.43) KDM4EKMT2ACHRM2CHRM5CHRM3
SCHEMBL28989190 0.76 NPC1 (0.48) MYCKDM4EKMT2AL3MBTL1BDKRB1
SCHEMBL26103588 0.76 MYC (0.49) OPRK1MYCKDM4EKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376503-B1 TREATMENT OF BENIGN PROSTATIC HYPERPLASIA MERCK & CO., INC 2002-04-23 US disclosed
EP-1023068-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2001-05-16 EP disclosed
EP-1023068-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2000-08-02 EP disclosed
WO-1998057638-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1998-12-23 WO disclosed